Garian, Wilmar D.

HRN: 28-68-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/26/2026
04/02/2026
IVTT
500mg
Q8H
CNSI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Central Nervous System    Compliance to guidelines: